Sonila’s practice focuses on the defense of companies in product liability and business litigation matters before state and federal courts. She has successfully represented Fortune 500 companies in the pharmaceutical, medical device, energy, chemical and consumer products industries in all phases of the litigation process, including discovery and depositions, motion practice, mediation, trial preparation, and settlement. Sonila has also advised chemical companies on litigation risks related to the supply of raw materials for use in medical devices and consumer products.  

Sonila is also committed to pro bono work. Her pro bono work includes representing a client in a contested divorce through jury trial, representing a client petitioning for asylum on the basis of FGM, and counseling members of the Albanian community of Houston on various immigration-related matters. Sonila has also mentored law students through the firm's Leadership Council on Legal Diversity program.

Earlier in her career, Sonila worked as a professor of English Rhetoric and Composition at Houston Community College and Lone Star College, where she also taught World Literature. Fluent in Albanian and Italian, she has worked as a translator and interpreter.

Representative Matters

Laporte v. Pharmacia & Upjohn Company LLC, Massachusetts Appeals Court (summary judgment obtained and affirmed, claim dismissed)


Update on Biomaterials Access Assurance Act Litigation, Drug and Device Bulletin, Shook, Hardy & Bacon, March 14, 2019.

How Wide are the Arms of State Court Jurisdiction?, The Houston Lawyer, November/December 2017.

Sonila Themeli, Comment, FCPA Enforcement and the Need for Judicial Intervention, 56 S. Tex. L. Rev. 387 (2014).

Media Coverage

Evidence of Nothing Overcomes No Evidence, Drug & Device Law, June 4, 2020.

Tufts Must Face Suit Over Patient’s Infection Death, Law360, June 1, 2020.